QUIDEL RSS Feed | Nachrichten - www.finanzen.net

Innovating Diagnostics and What's Next

Thu, 18 Dec 2025 15:17:00 +0100

SAN DIEGO, Dec. 18, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in in ...

QuidelOrtho To Participate In Upcoming Investor Conferences

Mon, 24 Nov 2025 13:00:00 +0100

SAN DIEGO, Nov. 24, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a global ...

The Power of Prevention: Detecting Diabetes Before It Strikes

Thu, 20 Nov 2025 15:00:00 +0100

SAN DIEGO, Nov. 20, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in in ...

QuidelOrtho Reports Third Quarter 2025 Financial Results

Wed, 05 Nov 2025 22:05:00 +0100

― Total revenue of $700 million; excluding COVID-19 and Donor Screening, revenue grew mid-single digits, demonstrating solid underlying growth and momentum ―

QuidelOrtho Receives FDA 510(k) Clearance for VITROS™ Immunodiagnostic Products hs Troponin I Assay

Mon, 03 Nov 2025 13:00:00 +0100

Clearance expands menu and enables high-sensitivity troponin I measurement to aid in the diagnosis of myocardial infarction

Informatics Illuminated: Science Bytes Podcast Explores the Power Behind Smarter Diagnostics

Fri, 24 Oct 2025 00:45:00 +0200

SAN DIEGO, Oct. 23, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in in ...

QuidelOrtho to Report Third Quarter 2025 Financial Results

Wed, 22 Oct 2025 13:00:00 +0200

SAN DIEGO, Oct. 22, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), ...

QuidelOrtho Showcases Leadership in Transfusion Medicine at AABB 2025

Fri, 17 Oct 2025 02:30:00 +0200

FDA-approved MTS™ DAT Card and advanced ORTHO VISION™ Platform highlight the company's continued leadership in transfusion medicine